IL137677A - Amino anthracyclinone derivatives, a process for their preparation and their use in the preparation of a medicament for the treatment of amyloidosis - Google Patents
Amino anthracyclinone derivatives, a process for their preparation and their use in the preparation of a medicament for the treatment of amyloidosisInfo
- Publication number
- IL137677A IL137677A IL13767799A IL13767799A IL137677A IL 137677 A IL137677 A IL 137677A IL 13767799 A IL13767799 A IL 13767799A IL 13767799 A IL13767799 A IL 13767799A IL 137677 A IL137677 A IL 137677A
- Authority
- IL
- Israel
- Prior art keywords
- preparation
- amyloidosis
- medicament
- amino
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/72—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9805080.0A GB9805080D0 (en) | 1998-03-10 | 1998-03-10 | Amino anthracyclinone derivatives |
PCT/EP1999/001300 WO1999046254A2 (en) | 1998-03-10 | 1999-02-25 | Amino anthracyclinone derivatives and their use in the treatment of amyloidosis |
Publications (2)
Publication Number | Publication Date |
---|---|
IL137677A0 IL137677A0 (en) | 2001-10-31 |
IL137677A true IL137677A (en) | 2005-08-31 |
Family
ID=10828304
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13767799A IL137677A (en) | 1998-03-10 | 1999-02-25 | Amino anthracyclinone derivatives, a process for their preparation and their use in the preparation of a medicament for the treatment of amyloidosis |
Country Status (23)
Country | Link |
---|---|
US (1) | US6268362B1 (xx) |
EP (1) | EP1062206B1 (xx) |
JP (1) | JP2002506066A (xx) |
KR (1) | KR100603798B1 (xx) |
CN (1) | CN1113867C (xx) |
AR (1) | AR019831A1 (xx) |
AT (1) | ATE264302T1 (xx) |
AU (1) | AU755754B2 (xx) |
BR (1) | BR9908057A (xx) |
CA (1) | CA2321834A1 (xx) |
DE (1) | DE69916438D1 (xx) |
EA (1) | EA003333B1 (xx) |
GB (1) | GB9805080D0 (xx) |
HU (1) | HUP0101046A3 (xx) |
ID (1) | ID26084A (xx) |
IL (1) | IL137677A (xx) |
NO (1) | NO317260B1 (xx) |
NZ (1) | NZ506945A (xx) |
PL (1) | PL193245B1 (xx) |
TW (1) | TW528751B (xx) |
UA (1) | UA51838C2 (xx) |
WO (1) | WO1999046254A2 (xx) |
ZA (1) | ZA991839B (xx) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITRM20110264A1 (it) * | 2011-05-27 | 2012-11-28 | Univ Degli Studi Milano | Nuovi composti triciclici glicofusi, procedimento per la loro produzione e loro impiego quali ligandi dei peptidi ss amiloidi (ass). |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL110289A (en) | 1993-08-06 | 1998-01-04 | Policlinico San Matteo Istitut | Pharmaceutical preparations containing 4-iodo-4-deoxydoxorubicin for the treatment of amyloidosis |
GB9416007D0 (en) | 1994-08-08 | 1994-09-28 | Erba Carlo Spa | Anthracyclinone derivatives |
GB9516349D0 (en) | 1995-08-09 | 1995-10-11 | Pharmacia Spa | Aza-anthracyclinone derivatives |
GB9613433D0 (en) | 1996-06-26 | 1996-08-28 | Pharmacia Spa | Fluoro labelled anthracyclinone and anthracycline derivatives |
-
1998
- 1998-03-10 GB GBGB9805080.0A patent/GB9805080D0/en not_active Ceased
-
1999
- 1999-02-11 TW TW088102135A patent/TW528751B/zh not_active IP Right Cessation
- 1999-02-25 IL IL13767799A patent/IL137677A/xx not_active IP Right Cessation
- 1999-02-25 EP EP99910304A patent/EP1062206B1/en not_active Expired - Lifetime
- 1999-02-25 CA CA002321834A patent/CA2321834A1/en not_active Abandoned
- 1999-02-25 PL PL344086A patent/PL193245B1/pl not_active IP Right Cessation
- 1999-02-25 HU HU0101046A patent/HUP0101046A3/hu unknown
- 1999-02-25 JP JP2000535634A patent/JP2002506066A/ja not_active Withdrawn
- 1999-02-25 EA EA200000922A patent/EA003333B1/ru not_active IP Right Cessation
- 1999-02-25 NZ NZ506945A patent/NZ506945A/en unknown
- 1999-02-25 ID IDW20001707A patent/ID26084A/id unknown
- 1999-02-25 CN CN99803596A patent/CN1113867C/zh not_active Expired - Fee Related
- 1999-02-25 BR BR9908057-5A patent/BR9908057A/pt not_active Application Discontinuation
- 1999-02-25 WO PCT/EP1999/001300 patent/WO1999046254A2/en not_active Application Discontinuation
- 1999-02-25 AT AT99910304T patent/ATE264302T1/de not_active IP Right Cessation
- 1999-02-25 UA UA2000105718A patent/UA51838C2/uk unknown
- 1999-02-25 AU AU29308/99A patent/AU755754B2/en not_active Ceased
- 1999-02-25 US US09/622,921 patent/US6268362B1/en not_active Expired - Fee Related
- 1999-02-25 DE DE69916438T patent/DE69916438D1/de not_active Expired - Lifetime
- 1999-02-25 KR KR1020007009971A patent/KR100603798B1/ko not_active IP Right Cessation
- 1999-03-08 ZA ZA9901839A patent/ZA991839B/xx unknown
- 1999-03-08 AR ARP990100974A patent/AR019831A1/es unknown
-
2000
- 2000-09-04 NO NO20004406A patent/NO317260B1/no unknown
Also Published As
Publication number | Publication date |
---|---|
ZA991839B (en) | 1999-12-22 |
EA200000922A1 (ru) | 2001-04-23 |
KR20010041737A (ko) | 2001-05-25 |
NO317260B1 (no) | 2004-09-27 |
EP1062206B1 (en) | 2004-04-14 |
CN1113867C (zh) | 2003-07-09 |
NO20004406L (no) | 2000-10-30 |
NO20004406D0 (no) | 2000-09-04 |
US6268362B1 (en) | 2001-07-31 |
ID26084A (id) | 2000-11-23 |
JP2002506066A (ja) | 2002-02-26 |
WO1999046254A3 (en) | 1999-10-21 |
ATE264302T1 (de) | 2004-04-15 |
GB9805080D0 (en) | 1998-05-06 |
AU755754B2 (en) | 2002-12-19 |
HUP0101046A2 (hu) | 2001-08-28 |
CN1291977A (zh) | 2001-04-18 |
DE69916438D1 (de) | 2004-05-19 |
AU2930899A (en) | 1999-09-27 |
PL193245B1 (pl) | 2007-01-31 |
EA003333B1 (ru) | 2003-04-24 |
HUP0101046A3 (en) | 2002-12-28 |
TW528751B (en) | 2003-04-21 |
EP1062206A2 (en) | 2000-12-27 |
NZ506945A (en) | 2002-06-28 |
IL137677A0 (en) | 2001-10-31 |
UA51838C2 (uk) | 2002-12-16 |
BR9908057A (pt) | 2000-10-31 |
CA2321834A1 (en) | 1999-09-16 |
WO1999046254A2 (en) | 1999-09-16 |
AR019831A1 (es) | 2002-03-20 |
KR100603798B1 (ko) | 2006-07-25 |
PL344086A1 (en) | 2001-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP9500743A0 (en) | New erythromycin derivatives, their preparation process and their use as medicaments | |
HK1020956A1 (en) | Oxadiazoles, processes for their preparation and their use as medicaments | |
HUP0104909A3 (en) | 2-amino-benzoxazinone derivatives for the treatment of obesity, process for their preparation and medicaments containing them | |
IL113245A0 (en) | New erythromycin derivatives their preparation process and their use as medicaments | |
HU9500849D0 (en) | Thiazolidine and oxazolidine derivatives, their preparation and their medical use | |
HUP0000658A3 (en) | Sulphonamide derivatives, process for their preparation, and their use as medicaments | |
IL126787A (en) | D-proline derivatives, medicaments against amyloidosis comprising them and a process for their preparation | |
HK1040980A1 (zh) | 聯苯磺酰基氨基氰、其製備方法及其作為藥物的用途 | |
PL332643A1 (en) | 1h-pyrido-[3,4-b]-indolo-4-carboxyamidic derivatives, their production and application in medical treatment | |
CZ63895A3 (en) | 5-vinyl-quinolone-carboxylic, 5-vinyl-naphthyridon-carboxylic, +5-ethinyl-quinolone-carboxylic and 5-ethinyl-naphthyridon-carboxylic acids, process of their preparation, medicaments in which said compounds are comprised and their use | |
ZA988285B (en) | 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-oles process for their preparation and their use for medicaments | |
HK1014938A1 (en) | Oxazolidinone derivatives, their preparation and therapeutical use | |
ZA978772B (en) | N-(2-benzothiazolyl)-1-piperidineethanamine derivatives, their preparation and their use in therapy. | |
IL137677A (en) | Amino anthracyclinone derivatives, a process for their preparation and their use in the preparation of a medicament for the treatment of amyloidosis | |
NZ320323A (en) | Amine derivatives of epipodophyllotoxin 2", 3"- dideoxyglycosides, preparation and use thereof as a drug and for treating cancer | |
HK1015763A1 (en) | Benzoxazindione derivatives, process for their preparation and their use | |
IL130831A (en) | Imino-aza-anthrayclinone derivatives, process for their preparation and pharmaceutical compositions comprising them for the treatment of amyloidosis | |
IL133536A0 (en) | 6-pyrrolidin-2-ylpyridine derivatives, their preparation and application in therapy | |
HUP9901870A3 (en) | 5alfa-reductase inhibitory preparation for oral administration, process for producing the same, and use thereof | |
EP0583698A3 (en) | Deoxy-cyclitol derivatives, process for their preparation and their use in medicaments. | |
IL149653A0 (en) | 2-arylquinoline derivatives, preparation and therapeutic use thereof | |
HUP0100584A3 (en) | Triazepinones, process for their preparation and their therapeutic application | |
HUP0003908A3 (en) | Use of substituted azaspirane in the manufacture of a medicament for use in treating asthma | |
GB9119714D0 (en) | Trifluoromethylketone derivatives, process for preparation thereof and use thereof | |
ZA9110200B (en) | Trifluoromethylketone derivatives,processes for preparation thereof and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees |